Conference milestone

Prevention Is Now Alzheimer’s Hardest Trial

Liver Cancer Is Moving Beyond TACE Alone

Microglia Are Not a Shortcut to Alzheimer’s Certainty

Tau Is Back. Certainty Is Not.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker

Duchenne Evidence Moves Into the Muscle

Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems

KRAS Has a New Contender. It Still Has to Earn Its Place.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
